Running-Related Injury (First-time)RRI_Interv4NCT03115437
Effects of Shoe Cushioning and Body Mass on Injury Risk in Running
A study testing Hard cushioned running shoes and Soft cushioned running shoes in people with Running-Related Injury (First-time), run by Luxembourg Institute of Health at 1 site in Luxembourg.
Trial summary
The main goal is to investigate the influence of shoe cushioning and body mass on the risk of running-related injury. This study will allow to determine if shoe cushioning needs to be adapted to the mass of the runner in order to minimize injury risk. Read more about this study
- Who is it for?
- Ages 18 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Running-Related Injury (First-time)
- What is being tested?
- Hard cushioned running shoes and Soft cushioned running shoes
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 874 participants
- Where
- 1 siteLuxembourg
- Study dates
- 20 Sep 2017to 31 Oct 2018
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Aged between 18 and 65 years
- Agree to perform running training minimum once a week
- Agree to use of the pair of running shoes delivered by the research team for each running training session, and only for running activities
- Agree to report all sporting activities, injuries and pains in the electronic system "TIPPS"
- Signed Informed consent
- Capable of performing 15 min of consecutive running
Who cannot join
- Any contraindication to running training and testing including cardiovascular/respiratory disease or running impeding injury/condition at the time of initial inclusion
- A history of surgery to the lower limbs or the back region within the previous 12 months or any degenerative conditions
- The use of insoles for physical activity
- Any current running-related injury
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Role of Shoe Cushioning, Body Mass and Running Biomechanics on Injury Risk: a Randomized Controlled Trial
The main goal is to investigate the influence of shoe cushioning and body mass on the risk of running-related injury. This study will allow to determine if shoe cushioning needs to be adapted to the mass of the runner in order to minimize injury risk. The influence of shoe cushioning on running technique will also be investigated.
This study consists in a 6-month follow-up period during which leisure-time runners are required to perform a running activity at least once a week and to upload all their running as well as other sporting activities onto a secured web-based training calendar named "Training and Injury Prevention Platform for Sports" (TIPPS) on a weekly basis. Any injury sustained during this period should also be uploaded onto the TIPPS system using the injury questionnaire provided on the website. Finally, the day of the visit to the laboratory (study start), their running style will be analysed during a 15-minute run on an instrumented treadmill at the participant's usual running speed. Anthropometric measurements will also taken.
Read more
Before the beginning of the study, the participants will receive a pair of running shoes free of charge. These shoes will either have a soft or hard sole. Both shoe versions have cushioning properties that correspond to the range of values from the shoes available on the market. They will be administered through random allocation. Neither the participants nor the research team will know which shoe version was provided to the participant, in order to respect the double-blinded methodology of this study. The participants will be required to use these shoes for all running sessions, and only for running activities.
Hypotheses:
H1: Running shoes with greater stiffness are associated with a higher injury risk in leisure-time runners.
H2: High body mass is associated with a higher injury risk in leisure-time runners.
H3: Runners with a high body mass experience a lower injury risk in shoes with greater stiffness.
H4: A higher step length, a lower step frequency, and higher peak vertical impact forces are associated with a higher injury risk.
H5: Running shoes with greater stiffness will be associated with higher vertical impact peak forces and a shorter contact time.
H6: High body mass will be associated with higher peak vertical impact forces, increased contact time, increased duty factor, and decreased step frequency.
Read the detailed description
The design of this study is a randomized controlled trial with an intervention period of six months and a biomechanical analysis of running pattern the day of inclusion in the study. Running footwear is provided by a renowned sport equipment manufacturer working in close collaboration with the Sports Medicine Research Laboratory (SMRL) of the Luxembourg Institute of Health (LIH), which in turn is responsible for the management and execution of the study. Random allocation of the study shoes, recruitment and follow-up of the participants, biomechanical testing, as well as data management and analysis will be carried out by the SMRL. The study design is based on the comparison between 2 running shoe prototypes, which only differ with respect to the cushioning (i.e. stiffness). The cushioning properties of both shoe versions will be within the range of values of models available on the market.
Recruitment:
Participants will be recruited through advertisements in local newspapers and press releases within the Grand-Duchy of Luxembourg during the months of September 2017 to January 2018. The benefits for the participants are strongly highlighted during the recruitment phase, and are as follows: 1) the use of a sports diary developed by the SMRL and called TIPPS (Training and Injury Prevention Platform for Sports, www.tipps.lu) to record all their sporting activities, quantify progress, and keep track of their sport-related injuries, 2) a free pair of running shoes, and 3) a brief report with the results of the biomechanical testing as well as their anthropometric measurements. However participants will be made aware that they will randomly receive one of the 2 study shoe versions to be worn during the observation period for all their running activities.
Registration procedure:
The participants must understand and agree on the randomized design of the study and that they will be allocated to one of the two running shoe groups. Anyone wishing to take part and believing themselves to meet the inclusion criteria will be invited to follow the process described hereafter:
Volunteers first have to create a personal account on TIPPS, pre-register to the study via their personal account, and answer an online inclusion/exclusion questionnaire as well as a baseline questionnaire. To finalize the registration, the participant will have to set an appointment with the research team via the TIPPS platform. Answers to both questionnaires will be assessed by the investigators during the initial visit.
Data collection:
The data collection phase of this project will last from September 2017 until July 2018. It consists of 2 different parts: an epidemiological study with 6-month follow-up and a biomechanical analysis of the participants' running pattern.
The follow-up period will start as soon as the participants have received their study shoes (from September 2017 to January 2018) and will finish at the latest on the 31st of July 2018.
The biomechanical analysis of the participants' running pattern will occur during their initial visit, using the study shoes that they will have received.
The initial visit of the participants at the SMRL will be the occasion 1) to verify the inclusion criteria, 2) to validate their answers to the online questionnaire, 3) to determine the appropriate shoe size, 4) to allocate each participant to one of the study arms according to the randomization list (see stratified randomization), 4) to deliver the shoes, 5) to collect some anthropometric measures, and 6) to perform the biomechanical test on the treadmill.
Stratified randomization:
A stratified block randomization will be prepared by the Competence Center for Methodology and Statistics of the LIH before the beginning of the recruitment. Participants will be stratified according to their sex because body mass (one of the two variables of interest) as well as many anthropometric characteristics are largely dependent on sex. Each block will include 40 participants.
Shoe types:
The study shoes are prototypes and will be anonymized for the purpose of this trial. The sole of the shoes will be customized so that the two running shoe prototypes will be exactly the same (same midsole, same outsole, same upper), except for their cushioning properties which will differ by more than 35%, while remaining within the range of the shoes available on the market. The difference in cushioning properties between the shoe versions will be created by modifying the midsole material, i.e. chemistry, density and therefore the hardness of the Ethylene Vinyl Acetate (EVA) foam. In order to provide accurate data on the technical specifications (i.e. stiffness ) of each shoe model, a set of 40 shoes (10 pairs per condition) will be tested for cushioning properties by the manufacturer according to a standardized protocol (Impact test: ASTM1614, Procedure A).
Data on exposure:
Data on running practices is collected using the TIPPS system. Required information in the sport activity report includes the type of activity, context, duration, subjectively perceived intensity, distance, shoe pair used, running surface (hard or soft), and whether the participant had experienced any pain during the session forcing him/her to reduce practice volume or intensity, or to interrupt the practice. Session intensity is determined using the Borg's rating of perceived exertion scale, a subjective 10-point scale.
Data on outcome:
The primary outcome is the first running-related injury. A consensus definition of running-related injury in recreational runners has been recently published. The definition of running-related injury is a "running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running (distance, speed, duration, or training) for at least 7 days or 3 consecutive scheduled training sessions, or that requires the runner to consult a physician or other health professional." Similar to uploading a training session or competition, the TIPPS provides a complete yet easy to fill in questionnaire when reporting an injury. Information regarding the following is required: injury date, context, sports discipline, injury mechanism (acute or progressive), anatomical location, type of injury, description and estimated return date. Running-related injury will be classified according to the Orchard Sports Injury Classification System version 10 (OSICS-10). Injury severity will be measured in days of modified or interrupted training.
Anthropometric measures:
The body composition (i.e. the proportion of muscle and fat tissues) will be assessed by bioelectrical impedance analysis (Tanita SC-240 MA).
Leg length will be defined as the measure between the anterior superior iliac spine and the medial malleolus, and is referred to as the "direct" clinical method. Additionally, the distance between the great trochanter and the ground will also be measured for the assessment of leg stiffness.
Biomechanical testing:
The biomechanical testing consists in a running test on an instrumented treadmill and will be performed in the study shoes, according to the random allocation. The test (10 minutes) consists of a 5-minute warm-up followed by a 5-minute run at the self-declared preferred (habitual) running speed. Two records of 45 seconds will be obtained over the last 2 minutes of the test.
Additionally, the participants who reported a preferred running speed equal to 10 km/h (+/- 1 km/h) will be invited to perform a second test at the end of the follow-up period. This second test will consist in 10 minutes of running in each shoe model. Records will be obtained during the last 2 minutes of each run. This will allow a within subject analysis of the shoe effect on running biomechanics at a standardized speed.
Sample size:
A sample size calculation for Cox regression was used to determine the number of participants needed for the primary hypothesis of the study. With an alpha of 0.05 and a power of 80%, an average injury rate of 30%, an expected HR=1.50 between groups, 50% of participants randomized to each shoe group and an expected drop-out rate of 20%, the total number of participants required is 802.
A within subject analysis will be performed on a subgroup of participants to investigate the effect of shoe condition on VGRF. A total sample of 39 participants will be required to detect a difference of 0.16 body weight (standard deviation: 0.25 body weight) between shoe conditions with 80% power and a significant level of 5%.
Statistical analysis:
Descriptive data for the personal, anthropometric, biomechanical and training-related characteristics will be presented as count and percentage for dichotomous variables, and as mean and standard deviation, or as median and range, respectively, for normally and non-normally distributed continuous variables. Average sport-related characteristics will be computed for each participant over their specific period of observation. Shock absorption properties of the two types of shoes will be compared using a Student's t test. A two-way analysis of variance (ANOVA) will be used to determine whether any difference in running biomechanics results from the shoe cushioning properties or body mass.
Cox proportional hazards regressions will be used to compute the hazard rates (HR) in the exposure groups, using first-time injury as the primary outcome. Date of inclusion (baseline evaluation date) and date of injury or of censoring will be basic data used to calculate the time at risk, which is expressed in hours spent running and defined as the time-scale. A participant will be right-censored if injury unrelated to running or severe disease caused a modification of the running plan, or at the end of follow-up. The assumption of proportional hazards will be evaluated by log-minus-log plots.
Unadjusted Cox regressions will be performed to present the crude estimates of HRs for shoe model, body mass and other potential risk factors such as running biomechanics variables and training-related characteristics. Body mass is an exposure that can change over time (time-dependent covariate). This means that each participant could move between exposure states continuously (every month in our study). A delayed entry will be used in the unadjusted Cox regression model for body mass.
Subsequently, the variables with a P value <0.200 will be included in the adjusted Cox regression analysis to determine whether shoe cushioning and/or body mass are associated with injury risk, controlling for potential confounders. The recommendation for using at least 10 injuries per predictor variable included in the Cox regression analysis will be strictly followed.
Finally, to investigate if the effect of shoe cushioning on injury risk is modified by body mass, a stratified analysis will be performed. HRs and their 95% confidence intervals (CI) will be determined within each stratum. All analyses will be performed using STATA/SE version 14.
- Conditions
- Running-Related Injury (First-time)
- Being tested
- Hard cushioned running shoes, Soft cushioned running shoes
- Keywords
- Body mass, Running-related injury, Sports injury prevention, Impact forces, Epidemiology, Running biomechanics, Sports footwear, Shoe cushioning
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Hard cushioned running shoesOther
Also called Hard
The participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by hard cushioning.
Soft cushioned running shoesOther
Also called Soft
The participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by soft cushioning.
| Study group | Role | What they receive |
|---|---|---|
| Hard cushioned running shoes | Experimental | Running shoes with cushioned properties among the hardest of the market benchmark (Stiffness: +/- 90 N/mm) Receives: Other: Hard cushioned running shoes |
| Soft cushioned running shoes | Experimental | Running shoes with cushioned properties among the softest of the market benchmark (Stiffness: +/- 57 N/mm) Receives: Other: Soft cushioned running shoes |
What is being measured
The primary outcome is the main question the study is designed to answer.
Running-related injury (First-time)
First running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running for at least 7 days or 3 consecutive scheduled training sessions.
Measured: 6 months
Secondary outcomes (14)
Running-related injury (subsequent)
Any subsequent running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running for at least 7 days or 3 consecutive scheduled training sessions.
Measured: 6 months
Step frequency (steps/min)
Steps per minute measured during the running technique analysis at baseline
Measured: Baseline
Contact time (ms)
Duration of the contact phase measured during the running technique analysis at baseline
Measured: Baseline
Flight time (ms)
Duration of the flight phase measured during the running technique analysis at baseline
Measured: Baseline
Duty factor (%)
Ratio between contact time and stride time
Measured: Baseline
Step length (m)
Distance between 2 consecutive steps of the same foot calculated based on running speed and stride time
Measured: Baseline
Vertical Impact Peak Force (N)
Amplitude of the first impact peak during the stance phase
Measured: Baseline
Peak Vertical Force (N)
Maximal value of the vertical force during the stance phase
Measured: Baseline
Vertical Instantaneous Loading Rate (N/s)
The steepest slope of the curve of vertical ground reaction force from initial contact to vertical impact peak force
Measured: Baseline
Vertical Average Loading Rate (N/s)
Average increase of vertical force from initial contact to vertical impact peak force
Measured: Baseline
Peak Power (W)
Highest value measure for power during the eccentric phase of the stance phase
Measured: Baseline
Time to Peak Power (ms)
Time from intial contact to peak power
Measured: Baseline
Leg stiffness (kN/m)
Maximal vertical ground reaction force divided by the peak displacement of the leg spring calculated from the initial leg length, running velocity and contact time.
Measured: Baseline
Vertical stiffness (kN/m)
Maximal vertical ground reaction force divided by the vertical displacement of the center of mass
Measured: Baseline
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Apr 2017
- Study start20 Sep 2017
- Primary completion31 Jul 2018
- Study completion31 Oct 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (8)Papers the sponsor has linked to this study.
- Other trials for Running-Related Injury (First-time)Studies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind
- Who is masked
- Participant, Care provider, Investigator, Outcomes assessor
- Enrolment
- 874 participants (actual)
Sponsor and investigators
- Lead sponsor
- Luxembourg Institute of Health
- Sponsor type
- Other government
- Collaborators
- DECATHLON SA
- Responsible party
- Principal investigator, Laurent Malisoux, PhD, Luxembourg Institute of Health
- Investigators
- Laurent Malisoux, PhD, Principal investigator, Luxembourg Institute of HealthDaniel Theisen, PhD, Study director, Luxembourg Institute of Health
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03115437
- Sponsor's protocol ID
- DOPH_SMRL_20161101
- Acronym
- RRI_Interv4
- Status last verified
- Feb 2019
- First submitted
- 30 Mar 2017
- Last updated
- 26 Feb 2019
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The IPD will not be shared.
Publications
Malisoux L, Delattre N, Urhausen A, Morio C, Theisen D. Association of Shoe Cushioning Perception and Comfort With Injury Risk in Leisure-Time Runners: A Secondary Analysis of a Randomised Trial. Eur J Sport Sci. 2025 Nov;25(11):e70063. doi: 10.1002/ejsc.70063.
PubMed 41122014Malisoux L, Gette P, Delattre N, Urhausen A, Theisen D. Gait asymmetry in spatiotemporal and kinetic variables does not increase running-related injury risk in lower limbs: a secondary analysis of a randomised trial including 800+ recreational runners. BMJ Open Sport Exerc Med. 2024 Jan 5;10(1):e001787. doi: 10.1136/bmjsem-2023-001787. eCollection 2024.
PubMed 38196940Malisoux L, Gette P, Delattre N, Urhausen A, Theisen D. Spatiotemporal and Ground-Reaction Force Characteristics as Risk Factors for Running-Related Injury: A Secondary Analysis of a Randomized Trial Including 800+ Recreational Runners. Am J Sports Med. 2022 Feb;50(2):537-544. doi: 10.1177/03635465211063909. Epub 2022 Jan 20.
PubMed 35049407Malisoux L, Gette P, Backes A, Delattre N, Theisen D. Lower impact forces but greater burden for the musculoskeletal system in running shoes with greater cushioning stiffness. Eur J Sport Sci. 2023 Feb;23(2):210-220. doi: 10.1080/17461391.2021.2023655. Epub 2022 Jan 19.
PubMed 35014593Malisoux L, Gette P, Backes A, Delattre N, Cabri J, Theisen D. Relevance of Frequency-Domain Analyses to Relate Shoe Cushioning, Ground Impact Forces and Running Injury Risk: A Secondary Analysis of a Randomized Trial With 800+ Recreational Runners. Front Sports Act Living. 2021 Nov 11;3:744658. doi: 10.3389/fspor.2021.744658. eCollection 2021.
PubMed 34859204Malisoux L, Delattre N, Meyer C, Gette P, Urhausen A, Theisen D. Effect of shoe cushioning on landing impact forces and spatiotemporal parameters during running: results from a randomized trial including 800+ recreational runners. Eur J Sport Sci. 2021 Jul;21(7):985-993. doi: 10.1080/17461391.2020.1809713. Epub 2020 Sep 12.
PubMed 32781913Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe Cushioning Influences the Running Injury Risk According to Body Mass: A Randomized Controlled Trial Involving 848 Recreational Runners. Am J Sports Med. 2020 Feb;48(2):473-480. doi: 10.1177/0363546519892578. Epub 2019 Dec 26.
PubMed 31877062Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe cushioning, body mass and running biomechanics as risk factors for running injury: a study protocol for a randomised controlled trial. BMJ Open. 2017 Aug 21;7(8):e017379. doi: 10.1136/bmjopen-2017-017379.
PubMed 28827268
Study at a glance
From the registry record, last updated by the sponsor on 26 Feb 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Role of Shoe Cushioning, Body Mass and Running Biomechanics on Injury Risk: a Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT03115437
- Acronym / sponsor ID
- RRI_Interv4 / DOPH_SMRL_20161101
- Conditions
- Running-Related Injury (First-time)
- Keywords
- Body mass, Running-related injury, Sports injury prevention, Impact forces, Epidemiology, Running biomechanics, Sports footwear, Shoe cushioning
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 874 participants (actual)
- Lead sponsor
- Luxembourg Institute of HealthOther government
- Collaborators
- DECATHLON SA
- Study start
- 20 Sep 2017 (actual)
- Primary completion
- 31 Jul 2018 (actual)
- Study completion
- 31 Oct 2018 (actual)
- First posted
- 14 Apr 2017 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The main goal is to investigate the influence of shoe cushioning and body mass on the risk of running-related injury. This study will allow to determine if shoe cushioning needs to be adapted to the mass of the runner in order to minimize injury risk. The influence of shoe cushioning on running technique will also be investigated.
This study consists in a 6-month follow-up period during which leisure-time runners are required to perform a running activity at least once a week and to upload all their running as well as other sporting activities onto a secured web-based training calendar named "Training and Injury Prevention Platform for Sports" (TIPPS) on a weekly basis. Any injury sustained during this period should also be uploaded onto the TIPPS system using the injury questionnaire provided on the website. Finally, the day of the visit to the laboratory (study start), their running style will be analysed during a 15-minute run on an instrumented treadmill at the participant's usual running speed. Anthropometric measurements will also taken.
Before the beginning of the study, the participants will receive a pair of running shoes free of charge. These shoes will either have a soft or hard sole. Both shoe versions have cushioning properties that correspond to the range of values from the shoes available on the market. They will be administered through random allocation. Neither the participants nor the research team will know which shoe version was provided to the participant, in order to respect the double-blinded methodology of this study. The participants will be required to use these shoes for all running sessions, and only for running activities.
Hypotheses:
H1: Running shoes with greater stiffness are associated with a higher injury risk in leisure-time runners.
H2: High body mass is associated with a higher injury risk in leisure-time runners.
H3: Runners with a high body mass experience a lower injury risk in shoes with greater stiffness.
H4: A higher step length, a lower step frequency, and higher peak vertical impact forces are associated with a higher injury risk.
H5: Running shoes with greater stiffness will be associated with higher vertical impact peak forces and a shorter contact time.
H6: High body mass will be associated with higher peak vertical impact forces, increased contact time, increased duty factor, and decreased step frequency.
Detailed description
The design of this study is a randomized controlled trial with an intervention period of six months and a biomechanical analysis of running pattern the day of inclusion in the study. Running footwear is provided by a renowned sport equipment manufacturer working in close collaboration with the Sports Medicine Research Laboratory (SMRL) of the Luxembourg Institute of Health (LIH), which in turn is responsible for the management and execution of the study. Random allocation of the study shoes, recruitment and follow-up of the participants, biomechanical testing, as well as data management and analysis will be carried out by the SMRL. The study design is based on the comparison between 2 running shoe prototypes, which only differ with respect to the cushioning (i.e. stiffness). The cushioning properties of both shoe versions will be within the range of values of models available on the market.
Recruitment:
Participants will be recruited through advertisements in local newspapers and press releases within the Grand-Duchy of Luxembourg during the months of September 2017 to January 2018. The benefits for the participants are strongly highlighted during the recruitment phase, and are as follows: 1) the use of a sports diary developed by the SMRL and called TIPPS (Training and Injury Prevention Platform for Sports, www.tipps.lu) to record all their sporting activities, quantify progress, and keep track of their sport-related injuries, 2) a free pair of running shoes, and 3) a brief report with the results of the biomechanical testing as well as their anthropometric measurements. However participants will be made aware that they will randomly receive one of the 2 study shoe versions to be worn during the observation period for all their running activities.
Registration procedure:
The participants must understand and agree on the randomized design of the study and that they will be allocated to one of the two running shoe groups. Anyone wishing to take part and believing themselves to meet the inclusion criteria will be invited to follow the process described hereafter:
Volunteers first have to create a personal account on TIPPS, pre-register to the study via their personal account, and answer an online inclusion/exclusion questionnaire as well as a baseline questionnaire. To finalize the registration, the participant will have to set an appointment with the research team via the TIPPS platform. Answers to both questionnaires will be assessed by the investigators during the initial visit.
Data collection:
The data collection phase of this project will last from September 2017 until July 2018. It consists of 2 different parts: an epidemiological study with 6-month follow-up and a biomechanical analysis of the participants' running pattern.
The follow-up period will start as soon as the participants have received their study shoes (from September 2017 to January 2018) and will finish at the latest on the 31st of July 2018.
The biomechanical analysis of the participants' running pattern will occur during their initial visit, using the study shoes that they will have received.
The initial visit of the participants at the SMRL will be the occasion 1) to verify the inclusion criteria, 2) to validate their answers to the online questionnaire, 3) to determine the appropriate shoe size, 4) to allocate each participant to one of the study arms according to the randomization list (see stratified randomization), 4) to deliver the shoes, 5) to collect some anthropometric measures, and 6) to perform the biomechanical test on the treadmill.
Stratified randomization:
A stratified block randomization will be prepared by the Competence Center for Methodology and Statistics of the LIH before the beginning of the recruitment. Participants will be stratified according to their sex because body mass (one of the two variables of interest) as well as many anthropometric characteristics are largely dependent on sex. Each block will include 40 participants.
Shoe types:
The study shoes are prototypes and will be anonymized for the purpose of this trial. The sole of the shoes will be customized so that the two running shoe prototypes will be exactly the same (same midsole, same outsole, same upper), except for their cushioning properties which will differ by more than 35%, while remaining within the range of the shoes available on the market. The difference in cushioning properties between the shoe versions will be created by modifying the midsole material, i.e. chemistry, density and therefore the hardness of the Ethylene Vinyl Acetate (EVA) foam. In order to provide accurate data on the technical specifications (i.e. stiffness ) of each shoe model, a set of 40 shoes (10 pairs per condition) will be tested for cushioning properties by the manufacturer according to a standardized protocol (Impact test: ASTM1614, Procedure A).
Data on exposure:
Data on running practices is collected using the TIPPS system. Required information in the sport activity report includes the type of activity, context, duration, subjectively perceived intensity, distance, shoe pair used, running surface (hard or soft), and whether the participant had experienced any pain during the session forcing him/her to reduce practice volume or intensity, or to interrupt the practice. Session intensity is determined using the Borg's rating of perceived exertion scale, a subjective 10-point scale.
Data on outcome:
The primary outcome is the first running-related injury. A consensus definition of running-related injury in recreational runners has been recently published. The definition of running-related injury is a "running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running (distance, speed, duration, or training) for at least 7 days or 3 consecutive scheduled training sessions, or that requires the runner to consult a physician or other health professional." Similar to uploading a training session or competition, the TIPPS provides a complete yet easy to fill in questionnaire when reporting an injury. Information regarding the following is required: injury date, context, sports discipline, injury mechanism (acute or progressive), anatomical location, type of injury, description and estimated return date. Running-related injury will be classified according to the Orchard Sports Injury Classification System version 10 (OSICS-10). Injury severity will be measured in days of modified or interrupted training.
Anthropometric measures:
The body composition (i.e. the proportion of muscle and fat tissues) will be assessed by bioelectrical impedance analysis (Tanita SC-240 MA).
Leg length will be defined as the measure between the anterior superior iliac spine and the medial malleolus, and is referred to as the "direct" clinical method. Additionally, the distance between the great trochanter and the ground will also be measured for the assessment of leg stiffness.
Biomechanical testing:
The biomechanical testing consists in a running test on an instrumented treadmill and will be performed in the study shoes, according to the random allocation. The test (10 minutes) consists of a 5-minute warm-up followed by a 5-minute run at the self-declared preferred (habitual) running speed. Two records of 45 seconds will be obtained over the last 2 minutes of the test.
Additionally, the participants who reported a preferred running speed equal to 10 km/h (+/- 1 km/h) will be invited to perform a second test at the end of the follow-up period. This second test will consist in 10 minutes of running in each shoe model. Records will be obtained during the last 2 minutes of each run. This will allow a within subject analysis of the shoe effect on running biomechanics at a standardized speed.
Sample size:
A sample size calculation for Cox regression was used to determine the number of participants needed for the primary hypothesis of the study. With an alpha of 0.05 and a power of 80%, an average injury rate of 30%, an expected HR=1.50 between groups, 50% of participants randomized to each shoe group and an expected drop-out rate of 20%, the total number of participants required is 802.
A within subject analysis will be performed on a subgroup of participants to investigate the effect of shoe condition on VGRF. A total sample of 39 participants will be required to detect a difference of 0.16 body weight (standard deviation: 0.25 body weight) between shoe conditions with 80% power and a significant level of 5%.
Statistical analysis:
Descriptive data for the personal, anthropometric, biomechanical and training-related characteristics will be presented as count and percentage for dichotomous variables, and as mean and standard deviation, or as median and range, respectively, for normally and non-normally distributed continuous variables. Average sport-related characteristics will be computed for each participant over their specific period of observation. Shock absorption properties of the two types of shoes will be compared using a Student's t test. A two-way analysis of variance (ANOVA) will be used to determine whether any difference in running biomechanics results from the shoe cushioning properties or body mass.
Cox proportional hazards regressions will be used to compute the hazard rates (HR) in the exposure groups, using first-time injury as the primary outcome. Date of inclusion (baseline evaluation date) and date of injury or of censoring will be basic data used to calculate the time at risk, which is expressed in hours spent running and defined as the time-scale. A participant will be right-censored if injury unrelated to running or severe disease caused a modification of the running plan, or at the end of follow-up. The assumption of proportional hazards will be evaluated by log-minus-log plots.
Unadjusted Cox regressions will be performed to present the crude estimates of HRs for shoe model, body mass and other potential risk factors such as running biomechanics variables and training-related characteristics. Body mass is an exposure that can change over time (time-dependent covariate). This means that each participant could move between exposure states continuously (every month in our study). A delayed entry will be used in the unadjusted Cox regression model for body mass.
Subsequently, the variables with a P value <0.200 will be included in the adjusted Cox regression analysis to determine whether shoe cushioning and/or body mass are associated with injury risk, controlling for potential confounders. The recommendation for using at least 10 injuries per predictor variable included in the Cox regression analysis will be strictly followed.
Finally, to investigate if the effect of shoe cushioning on injury risk is modified by body mass, a stratified analysis will be performed. HRs and their 95% confidence intervals (CI) will be determined within each stratum. All analyses will be performed using STATA/SE version 14.
Study design
- Primary purpose
- Prevention
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Quadruple blind (participant, care provider, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Hard cushioned running shoes | Experimental | Other: Hard cushioned running shoesRunning shoes with cushioned properties among the hardest of the market benchmark (Stiffness: +/- 90 N/mm) |
| Soft cushioned running shoes | Experimental | Other: Soft cushioned running shoesRunning shoes with cushioned properties among the softest of the market benchmark (Stiffness: +/- 57 N/mm) |
Who may qualify
- Ages
- 18 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (6 listed)
- Aged between 18 and 65 years
- Agree to perform running training minimum once a week
- Agree to use of the pair of running shoes delivered by the research team for each running training session, and only for running activities
- Agree to report all sporting activities, injuries and pains in the electronic system "TIPPS"
- Signed Informed consent
Key exclusion criteria (4 listed)
- Any contraindication to running training and testing including cardiovascular/respiratory disease or running impeding injury/condition at the time of initial inclusion
- A history of surgery to the lower limbs or the back region within the previous 12 months or any degenerative conditions
- The use of insoles for physical activity
- Any current running-related injury
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Hard cushioned running shoesAlso: HardThe participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by hard cushioning. | Other | Hard cushioned running shoes |
| Soft cushioned running shoesAlso: SoftThe participants allocated to this experimental group will have to perform all their running sessions with the study shoes they received the day of their inclusion to the study and characterized by soft cushioning. | Other | Soft cushioned running shoes |
Primary outcome
Running-related injury (First-time)
Time frame: 6 months
First running-related (training or competition) musculoskeletal pain in the lower limbs that causes a restriction on or stoppage of running for at least 7 days or 3 consecutive scheduled training sessions.
14 secondary outcomes
Running-related injury (subsequent)
Time frame: 6 months
Step frequency (steps/min)
Time frame: Baseline
Contact time (ms)
Time frame: Baseline
Flight time (ms)
Time frame: Baseline
Duty factor (%)
Time frame: Baseline
Step length (m)
Time frame: Baseline
Vertical Impact Peak Force (N)
Time frame: Baseline
Peak Vertical Force (N)
Time frame: Baseline
Vertical Instantaneous Loading Rate (N/s)
Time frame: Baseline
Vertical Average Loading Rate (N/s)
Time frame: Baseline
Peak Power (W)
Time frame: Baseline
Time to Peak Power (ms)
Time frame: Baseline
Leg stiffness (kN/m)
Time frame: Baseline
Vertical stiffness (kN/m)
Time frame: Baseline
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 26 Feb 2019.
- Derived from this study: PubMed 41122014Malisoux L, Delattre N, Urhausen A, Morio C, Theisen D. Association of Shoe Cushioning Perception and Comfort With Injury Risk in Leisure-Time Runners: A Secondary Analysis of a Randomised Trial. Eur J Sport Sci. 2025 Nov;25(11):e70063. doi: 10.1002/ejsc.70063.
- Derived from this study: PubMed 38196940Malisoux L, Gette P, Delattre N, Urhausen A, Theisen D. Gait asymmetry in spatiotemporal and kinetic variables does not increase running-related injury risk in lower limbs: a secondary analysis of a randomised trial including 800+ recreational runners. BMJ Open Sport Exerc Med. 2024 Jan 5;10(1):e001787. doi: 10.1136/bmjsem-2023-001787. eCollection 2024.
- Derived from this study: PubMed 35049407Malisoux L, Gette P, Delattre N, Urhausen A, Theisen D. Spatiotemporal and Ground-Reaction Force Characteristics as Risk Factors for Running-Related Injury: A Secondary Analysis of a Randomized Trial Including 800+ Recreational Runners. Am J Sports Med. 2022 Feb;50(2):537-544. doi: 10.1177/03635465211063909. Epub 2022 Jan 20.
- Derived from this study: PubMed 35014593Malisoux L, Gette P, Backes A, Delattre N, Theisen D. Lower impact forces but greater burden for the musculoskeletal system in running shoes with greater cushioning stiffness. Eur J Sport Sci. 2023 Feb;23(2):210-220. doi: 10.1080/17461391.2021.2023655. Epub 2022 Jan 19.
- Derived from this study: PubMed 34859204Malisoux L, Gette P, Backes A, Delattre N, Cabri J, Theisen D. Relevance of Frequency-Domain Analyses to Relate Shoe Cushioning, Ground Impact Forces and Running Injury Risk: A Secondary Analysis of a Randomized Trial With 800+ Recreational Runners. Front Sports Act Living. 2021 Nov 11;3:744658. doi: 10.3389/fspor.2021.744658. eCollection 2021.
- Derived from this study: PubMed 32781913Malisoux L, Delattre N, Meyer C, Gette P, Urhausen A, Theisen D. Effect of shoe cushioning on landing impact forces and spatiotemporal parameters during running: results from a randomized trial including 800+ recreational runners. Eur J Sport Sci. 2021 Jul;21(7):985-993. doi: 10.1080/17461391.2020.1809713. Epub 2020 Sep 12.
- Derived from this study: PubMed 31877062Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe Cushioning Influences the Running Injury Risk According to Body Mass: A Randomized Controlled Trial Involving 848 Recreational Runners. Am J Sports Med. 2020 Feb;48(2):473-480. doi: 10.1177/0363546519892578. Epub 2019 Dec 26.
- Derived from this study: PubMed 28827268Malisoux L, Delattre N, Urhausen A, Theisen D. Shoe cushioning, body mass and running biomechanics as risk factors for running injury: a study protocol for a randomised controlled trial. BMJ Open. 2017 Aug 21;7(8):e017379. doi: 10.1136/bmjopen-2017-017379.
- Official website of the Luxembourg Institute of HealthLink provided by the sponsor.
- Individual participant dataSharing planned: No. The IPD will not be shared.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Laurent Malisoux, PhD principal investigator
Luxembourg Institute of Health
Daniel Theisen, PhD study director
Luxembourg Institute of Health
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Hard cushioned running shoes and Soft cushioned running shoes in people with Running-Related Injury (First-time), run by Luxembourg Institute of Health at 1 site in Luxembourg.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 6 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 26 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Luxembourg. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Running-related injury (First-time) (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT03115437, which also lists 8 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Feb 2019.